Lisa Flowers
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Lisa Flowers sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Lisa Flowers: 4 sponsored US clinical trials, 2 recruiting.
Lisa Flowers sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HPV-Related Anal Squamous Cell Carcinoma, with 1 trials.
Upper-quartile sponsor footprint
Lisa Flowers sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Safety of Anal Curcumin
NCT06626230
Screening Strategies Among High-risk Populations for Anal Cancer
NCT06628570
Topical Curcumin for HPV Related Cervical Disease
NCT04266275
Topical Curcumin for Precancer Cervical Lesions
NCT02944578
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Lisa Flowers pipeline
2 recruiting of 4 indexed (50% open).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: HPV-Related Anal Squamous Cell Carcinoma (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Lisa Flowers: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Lisa Flowers sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Lisa Flowers page
4 registered trials is a research-attention snapshot, not an endorsement of Lisa Flowers or any single study.
- 2 of Lisa Flowers's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HPV-Related Anal Squamous Cell Carcinoma is the condition Lisa Flowers studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HPV-Related Anal Squamous Cell Carcinoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Lisa Flowers pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.